Prediction of Drug-Drug Interactions based on Time-Dependent Inhibition from High Throughput Screening of Cytochrome P450 3A4 Inhibition
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-12-25
著者
-
Kato Motohiro
Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
-
Kato Motohiro
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Aso Yoshinori
Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
-
Aso Yoshinori
Fuji Gotemba Research Laboratories Chugai Pharmaceutical Company Ltd.
-
Nabuchi Yoshiaki
Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
-
Nabuchi Yoshiaki
Fuji Gotemba Research Laboratories Chugai Pharmaceutical Company Ltd.
-
Kawanishi Takehiko
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Mitsui Tetsuya
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Nabuchi Yoshiaki
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Aso Yoshinori
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
SEKIGUCHI Nobuo
Pre-Clinical Research Department, Chugai Pharmaceutical Co., Ltd.
-
HIGASHIDA Atsuko
Discovery Platform Technology Department, Chugai Pharmaceutical Co., Ltd.
-
TAKANASHI Kenji
Pre-Clinical Research Department, Chugai Pharmaceutical Co., Ltd.
-
ISHIGAI Masaki
Pre-Clinical Research Department, Chugai Pharmaceutical Co., Ltd.
-
Ishigai Masaki
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Sekiguchi Nobuo
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Higashida Atsuko
Discovery Platform Technology Department Chugai Pharmaceutical Co. Ltd.
関連論文
- Evaluation of Methods for Prediciting Drug-drug Interactions by Monte Carlo Simulation
- The determination of 2β-(3-hydroxypropoxy)-1α,25-dihydroxy vitamin D_3 (ED-71) in human serum by high-performance liquid chromatography-electrospray tandem mass spectrometry
- Prediction of Drug-Drug Interactions based on Time-Dependent Inhibition from High Throughput Screening of Cytochrome P450 3A4 Inhibition
- Transport mechanism of basic compounds through bio-mimetic artificial membrane
- The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotein-Quantitative Analysis Based on Information from the Literature
- Intestinal First-Pass Metabolism of CYP3A4 Substrates
- Estimation of the Interindividual Variability of Cytochrome 2D6 Activity from Urinary Metabolic Ratios in the Literature
- Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans - toxicological implications
- Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans - toxicological implications